Search

Search Constraints

You searched for: Author/Creator Danylesko, Ivetta

Search Results

1. A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia. (21st November 2020)

3. Immunogenicity and safety of the BNT162b2 mRNA COVID‐19 vaccine in haematopoietic stem cell transplantation recipients. (28th October 2021)

4. Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning. Issue 10 (19th July 2017)

7. Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel. Issue 14 (6th December 2022)

8. Risk factors and implications of oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation. (12th August 2019)

10. Venetoclax is safe and efficacious in relapsed/refractory AML. Issue 9 (28th July 2020)